Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALLBenedetta Accordi, Giuseppe Basso|PLoS ONE|2010Cited by 48
SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric ETV6-RUNX1 B-Acute Lymphoblastic Leukemia PatientsValentina Serafin, Benedetta Accordi|International Journal of Molecular Sciences|2019Cited by 10